home > ict > winter 2020 > removing barriers for paediatric patients in clinical trials
International Clinical Trials

Removing Barriers for Paediatric Patients in Clinical Trials

Designed by Katemangostar / Freepik

As scientific breakthroughs in healthcare advance, our ability to discover and diagnose diseases earlier has renewed the need for paediatric research. However, there has been a growing tension between the need to license medication, strict regulations, and the recognised unprofitability of conducting trials in the paediatric population.

A major consideration in paediatric trials involves balancing the rights, safety, and well-being of children while meeting financial requirements to enable the production of safe, licensed medication. Perceived challenges in striking this balance may be a deterrent for some pharmaceutical companies.

Some of the key challenges include a lack of paediatric trials, leading to fewer licensed medications for children, misconceptions and mistrust participants may have in research, which may hinder participation in clinical trials, and how the industry may influence paediatric research through community education, with a hope that children will not be left behind as healthcare research continues to progress.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Evelyn Kamau is the Global Head of Nursing at the MRN and has over 20 years’ nursing experience. Evelyn has worked in critical care, haemodialysis and neurology centres both in the UK and her native country Kenya. Evelyn has been a lecturer for both undergraduate and postgraduate nursing students, a position that led her to the neurosurgery department at Cambridge University, where she was involved in pioneering research in the understanding and management of disorders of consciousness. She left Cambridge University to manage community-based trials at the MRN in 2016.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Finalists Showcase Innovations in Sustainable Pharmaceutical Packaging, with Winners to be Announced at Connect in Pharma

London, UK – 25 May 2023 – Sciad Newswire – YewMaker and Connect In Pharma announce today the shortlisted finalists for this year’s Sustainable Medicines Packaging Awards. Winners will be announced at an in-person champagne ceremony at Connect In Pharma, an annual event connecting innovators in pharma and biotech to the world’s leading suppliers and manufacturers.
More info >>

White Papers

The Power of Execution in Clinical Research


Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement